Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Posts Earnings Results

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) posted its quarterly earnings data on Tuesday. The company reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.13 by ($0.02), Zacks reports. Bayer Aktiengesellschaft had a positive return on equity of 16.77% and a negative net margin of 3.80%.

Bayer Aktiengesellschaft Trading Down 0.3%

Shares of BAYRY stock opened at $13.95 on Tuesday. The firm has a market cap of $54.82 billion, a P/E ratio of 8.95, a PEG ratio of 1.94 and a beta of 0.57. Bayer Aktiengesellschaft has a 1-year low of $7.48 and a 1-year high of $15.23. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.04 and a quick ratio of 0.67. The firm’s 50-day simple moving average is $13.43 and its 200-day simple moving average is $12.55.

Wall Street Analyst Weigh In

Separately, Zacks Research raised Bayer Aktiengesellschaft from a “hold” rating to a “strong-buy” rating in a research report on Friday, July 10th. Two equities research analysts have rated the stock with a Strong Buy rating, five have given a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy”.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft is a Germany-based life sciences company headquartered in Leverkusen. Founded in 1863 by Friedrich Bayer and Johann Friedrich Weskott, the company develops products in health care and agriculture and serves customers in markets around the world.

Bayer operates through three primary businesses: Pharmaceuticals, Consumer Health and Crop Science. Its Pharmaceuticals segment develops prescription medicines in areas such as cardiovascular disease, women’s health, oncology, hematology and specialty therapies.